As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

With spring break approaching, now is the perfect time to focus on shedding unwanted fat and achieving a leaner physique.

Eating too fast could be making you gain weight without realizing it. Discover how slowing down can help regulate appetite and improve metabolism.

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, Ratings reports. Two analysts ...

If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Investorideas , a recognized top 100 investment site for stock news announces today's IPO's to watch in the Biotech, Technology, Homebuilder, Aerosp ...

March 7, 2025 (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

As consumers who use GLP-1 drugs seek lean, protein-rich foods, the demand for ground turkey has been increasing.

A study in The American Journal of Pathology reveals an unexpected discovery: mice lacking the CD44 protein remain lean even ...

HOLLYWOOD’S award season is in full swing – and it’s abundantly clear the super-skinny celebrity look is back with a ...